NCT06127394

Brief Summary

The goal of this clinical trial is to evaluate the catheter related bladder discomfort in patients who will undergoing TUR-P operation. The main questions it aims to answer are:

  • Is sacral ESPB effective on the pudendal nerve dermatome?
  • Is sacral ESPB as useful as pudendal block on CRBD? Participants will be divided into two groups and the first group will receive sacral espb after TUR-p operation and the second group will receive pudendal block. Investigators will be present for 24 hours
  • catheter related bladder discomfort
  • post-operative pain,
  • additional analgesic needs will be questioned and the difference between the two groups will be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

November 12, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 13, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2023

Completed
Last Updated

May 17, 2024

Status Verified

May 1, 2024

Enrollment Period

1 month

First QC Date

November 7, 2023

Last Update Submit

May 15, 2024

Conditions

Keywords

regional blockpudendal block

Outcome Measures

Primary Outcomes (1)

  • Catheter related bladder discomfort, 0:no discomfort 4:worst discomfort

    It was evaluated with a 4-point scoring system developed and first used by Agarwall et al. . No symptoms: 0, Mild: mild discomfort that can be tolerated, Moderate: discomfort is present but not accompanied by behavioural reactions, Severe: discomfort is very severe and accompanied by body movements indicating that the patient cannot bear it.

    baseline ,and 24 hours

Secondary Outcomes (1)

  • Numerical Rating Scale,0 :no pain 10:worst pain

    baseline, and 24 hours

Study Arms (2)

espb group

EXPERIMENTAL

Block will be performed with median technique at the level of sacral 2nd vertebrae.

Procedure: Sacral ESP Block

pudendal group

ACTIVE COMPARATOR

Bilateral transperineal block will be performed

Procedure: Pudendal Block

Interventions

Sacral ESPB median approach, 40 ml %0,25 Bupivacaine

espb group

Bilateral pudendal block, 10 ml %0,25 bupivacaine

pudendal group

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsOnly males have got prostate
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- American Society of Anesthesiologist (ASA) Physical status 1-3

You may not qualify if:

  • American Society of Anesthesiologist (ASA) Physical status 4-5
  • Refused to participate in the study
  • Known allergy to local anaesthetic
  • Where regional anaesthesia is contraindicated
  • With known neurological, haematological or muscular disease
  • Patients with infection or anatomical changes in the lumbo-sacral region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Giresun Research and Training Hospital

Merkez, Giresun, 28100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Bilge Olgun Keleş

    Giresun University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

November 7, 2023

First Posted

November 13, 2023

Study Start

November 12, 2023

Primary Completion

December 15, 2023

Study Completion

December 15, 2023

Last Updated

May 17, 2024

Record last verified: 2024-05

Locations